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Background: The use of Complementary and Alternative Medicine (CAM) in Inflammatory Bowel Disease (IBD) is
increasing. Although CAM often improves patients’ well-being, it can also lead to side-effects and interactions with
conventional medications. Research on patients with IBD in Sweden who have experiences of CAM is sparse. More
studies are needed to enhance awareness of and improve communication about CAM. The aim of this study was
to describe experiences of CAM in the healthcare context reported by patients with IBD.
Methods: Fifteen patients with IBD, eight with Crohn’s disease (CD) and seven with ulcerative colitis (UC), were
recruited. Semi-structured qualitative interviews were conducted and qualitative content analysis was performed.
Results: The analysis revealed the theme Knowledge and communication lead to participation in the area of CAM
based on three categories; CAM use, Communication and Self-care. Patients with IBD wanted to be asked about
CAM to be able to start a dialogue, as some perceived being treated in a disparaging manner and not taken
seriously when raising the subject. Healthcare professionals (HCPs) need to be aware of this in order to meet and
understand patient needs. Patients with IBD found it easier to communicate about CAM with the IBD nurses than
physicians and dietary changes was one important CAM treatment.
Conclusions: The finding that it was easier to discuss CAM with nurses than physicians emphasizes the important
role of the IBD nurse in communication and monitoring patients’ CAM use. Patients wanted to be asked about
CAM to be able to start a dialogue, as some perceived not taken seriously when raising the subject. Furthermore,
HCPs need to understand that many patients with IBD regard dietary changes as an important part of CAM
treatment. Further research in these areas is needed.
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The World Health Organization (WHO) defines Comple-
mentary and Alternative Medicine (CAM) as a broad set
of healthcare practices, systems and products that are not
generally considered part of the country’s own tradition
and are not integrated into the main healthcare system
[1]. What constitutes CAM differs from country to coun-
try. CAM can be categorized into five domains: whole
medical systems, mind-body interventions, biologically-
based therapies, manipulative and body-based methods* Correspondence: annelie.lindberg@ds.se
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unless otherwise stated.and energy therapies. Whole medical systems comprise
theories and practices such as homeopathic medicine,
Traditional Chinese Medicine and Ayurveda. Mind-body
interventions strengthen communication between the
mind and body, for example meditation, prayer and heal-
ing. Biologically-based therapies involve substances found
in nature, including dietary supplements and herbal
products. Manipulative and body-based methods employ
human touch to move or manipulate a specific part of
the body, for example, chiropractic therapy and massage.
Energy therapies use energy fields in the body to promote
health and healing, for example qi gong, tai chi and mag-
net therapy [2]. Complementary medicine refers to the
use of CAM in combination with conventional medicine,al Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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Age, mean years (range) 45 (20–80)
CD/UC 8/7
Disease duration, mean years (range) 14 (2–34)
Education – less than 12 years/more than 12 years 10/5
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stead of conventional medicine. Integrative medicine
combines both conventional and evidence based CAM
treatment [2].
CAM use has increased in the Scandinavian countries
[3]. In Norway and Denmark, half and one third of hos-
pitals, respectively, offer CAM to patients [4]. The popu-
lation of Sweden is 9.7 million inhabitants, of whom 2.1
million live in the capital Stockholm. CAM use in
Stockholm has increased from 22% in 1980 to 49% in
2002 [5]. Although CAM is becoming more common
in all parts of Sweden, studies have mostly been pub-
lished in less renowned journals. The Swedish Research
Council for Health, Working Life and Welfare (FAS) has
highlighted the importance of determining CAM use. In
view of the increasing prevalence of CAM, more evi-
dence based research is required [5]. In Sweden, health-
care is financed by taxes and all citizens have the right
to healthcare on equal terms [6]. There is no national
CAM policy in Sweden, and it is not officially approved
in healthcare or in the education system, thus policy de-
velopment is essential [7]. Interest in CAM is growing
among patients with chronic diseases [8,9] including in-
flammatory bowel diseases (IBD) [10-12].
IBD is a group of inflammatory conditions of the colon
and small intestine, most commonly ulcerative colitis
(UC) and Crohn’s disease (CD). They are chronic, inter-
mittently relapsing diseases with inflammation and ulcer-
ation of the digestive tract. The symptoms range from
mild to severe and include abdominal cramps with fre-
quent diarrhoea, bowel urgency and occasionally fever
[13]. IBD can be severely disabling and affect quality of
life as well as the ability to live a normal life [14-16]. The
medical treatment may also have a major impact on pa-
tients’ health-related quality of life (HRQOL) and the
main challenge is to combine therapies with minimal side
effects and optimal quality of life [17,18]. The cause of
IBD is unknown and there is no medical cure, although
several therapeutic advances have been made in recent
years. The complexity of IBD treatment has increased, as
the use of new immunomodulation agents [17,19,20]. IBD
can be associated with liver and biliary tract disorders
[21,22], which makes it especially important to be aware
that some CAM treatments such as herbal medicinal
products [23] and noni juice (Morinda citrifolia) may be
associated with liver toxicity [24,25]. Massage, natural
remedies, relaxation, yoga and counselling has been shown
to be the most commonly used CAM therapies in Swedish
IBD patients [26]. Reasons for CAM use may be lack of ef-
ficacy of conventional IBD therapy [12,27], steroid treat-
ment side-effects [28], stress and wish for a holistic
approach [29] or greater control over the disease [30].
Research has revealed communication gaps between
physicians and patients with regard to CAM [31-33] andfew clinicians routinely initiate discussions about it with
patients [33,34]. Communication style can have an im-
pact on health outcomes and patients of physicians who
employ a participatory decision-making style have better
health outcomes [35,36] and may also be more willing to
mention their CAM use [37].
There is a growing need to educate HCPs about CAM,
as knowledge of possible effects and interaction risks is
essential [38]. HCPs have expressed the need for CAM
education in order to provide optimal advice [39-41]. To
understand the needs of patients with IBD it is essential
for Healthcare professionals (HCPs) to have knowledge
of their experiences and expectations of CAM. The aim
was to describe experiences of CAM in the healthcare
context reported by patients with IBD.Methods
This study was based on qualitative interviews. The
qualitative method provides a deeper understanding of a
phenomenon by focusing on words in the collection and
analysis of data [42,43].Participants
The respondents comprised 15 patients with IBD, 8 with
CD and 7 with UC, recruited from 2 out-patient IBD
clinics in one urban area of Sweden. The respondents
were 9 women and 6 men, ranging in age from 20–80
years (mean 45 years), with a disease duration of 2–34
years (Table 1). All those invited agreed to participate in
the study. Purposeful sampling was used to obtain as
much variation as possible in terms of experience and to
gain insight into the phenomenon of CAM as experi-
enced by patients with IBD [43]. The purposeful sam-
pling was based on the following variables: diagnosis,
gender, age and disease duration.Data collection
All the interviews were conducted in a quiet, private
room at the out-patient clinic. Before the interview the
respondents provided their written informed consent.
The interviews lasted from 15–50 minutes.
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The study was approved by the Regional Ethical Review
Board in Stockholm, Sweden (no. 2008/4:6). All respon-
dents were assured of confidentiality, and informed that
participation was voluntary and that they could with-
draw at any time.
Data analysis
A qualitative content analysis method was used in ac-
cordance with Krippendorf [42]. Content analysis is a
step-wise technique for analysing the content of a text in
its context [42,43]. The transcripts were analysed using
manifest and latent content analysis. The former refers
to the obvious meaning of the text while the latter com-
prises interpretive reading in order to capture its deep
structural meaning [43].
The interviews were recorded, transcribed verbatim
and read several times to become familiar with the text.
The qualitative software NVivo 10 was used for coding
and analysing. Meaning units corresponding to the aim
of the study were extracted, coded and grouped into
sub-categories, categories and the theme. In order to
strengthen credibility, the analysis was conducted inde-
pendently by each of the authors, after which they dis-
cussed and achieved agreement about the findings [44].
Results
The analysis revealed the theme Knowledge and com-
munication lead to participation in the area of CAM
based on three categories; CAM use, Communication
and Self-care as well as fourteen sub-categories. The
findings are presented under each category (Table 2).
CAM use
The category CAM use comprised the sub-categories:
Changed dietary habits, Factors that influence CAM use,
Experience of CAM, Trust in CAM, No need of CAM,
Doubtful about CAM as well as Science and safety.
Some of the respondents considered that an important
part of CAM was changed dietary habits, such as ex-
cluding gluten, lactose, dairy products, sugar, flour,
E-numbers, raw meat and reducing calorie intake. They
reported an improvement in their bowel disease as a re-
sult of various dietary changes but that they had not re-
ceived sufficient support from HCPs in implementing
the changes.
I have been told that it doesn’t matter what you eat
which sounds quite absurd to someone who suffers
from bowel disease.
The respondents mentioned several factors that influ-
ence CAM use such as side effects or when conventional
treatment failed to produce the desired effect. They didnot want to use corticosteroids and perceived taking
many conventional medications as traumatic, although
they were prepared to try everything, as long as it had a
positive effect.
Anything that will make me better is OK.
The respondents perceived the HCPs as interested and
open to CAM but lacking in knowledge and that they
therefore needed information and education about
CAM.
The Health Authority ought to provide HCPs with
information about CAM on a regular basis.
CAM provided an opportunity for the body to heal it-
self and regain its balance. The respondents believed it
important to have a holistic view of the human being
and that CAM was perceived as exciting and popular,
which was mainly due to reports in the media. Some
considered CAM expensive and therefore did not use it
to any great extent.
But also the fact that CAM seems to be accepted in
society is largely due to the media.
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younger people being more open to CAM, searching for
information and having greater demands.I think that younger persons place different demands
and perhaps search for information themselves on the
Internet.
I think that older people have greater confidence in the
doctor’s knowledge about medications and thus are
slower [to adopt CAM].
The respondents had experience of CAM. The major-
ity had tried some type of dietary change during their ill-
ness in an effort to alleviate the disease, for example
excluding carbohydrates, sugar and products containing
solanine, such as potatoes, paprika and tomatoes. The
respondents had boiled Chinese herbs, which they drank
as tea and some had tried Probiotics with varying
results.
I don’t know if it was [probiotics] but I think so. It was
really strong and I experienced a great difference at
the beginning.
Some of the respondents found massage and yoga ef-
fective for reducing stress and increasing their energy
levels, thus alleviating IBD symptoms.
It reduces the pain, the blood circulation is activated
by the massage and I feel better and more relaxed, less
stressed and my breathing is calmer.
A number of respondents had used aloe vera juice and
found it beneficial and a few had tried acupuncture but
did not find that it had any effect on the IBD. None of
the respondents who had tried CAM at least once for
their IBD had been recommended to do so by HCPs but
had searched for the information, initiated and paid for
the treatment on their own initiative.
The respondents had trust in CAM, considered it valu-
able and that it had a place in healthcare. Some of them
expressed that they experienced CAM as positive in that
it reduced the negative effect of, for example, stress.
I don’t think that CAM has any influence on the
disease as such but on things around it.
Some respondents had a special interest in CAM and
had attended courses on the subject. They argued that
certain CAM methods were more accepted than others
and that it was definitely worth trying.You have to proceed by trial and error, but it’s
absolutely worth trying. I sort of have no choice. I also
think that it’s possible to prevent, support.
Some of the respondents stated that they had no need
of CAM and trusted their doctor. They did not miss
CAM, nor did they search actively or ask HCPs for in-
formation about it.
I’ve never considered trying CAM because I trust the
health services, that they know what they are doing,
it’s as simple as that.
Some of the respondents mentioned having an am-
bivalent attitude, being doubtful about CAM, skeptical
and not interested in using CAM methods. Others re-
ported feeling doubtful about herbal treatment. Uncer-
tainty as to whether CAM should be incorporated into
healthcare also emerged.
Then there are things that I haven’t tried, herbal
medicines and such, I don’t trust them as much,
because I have too little knowledge about them. My
gut feeling is that there’s too much humbug in that
area and a lot of desperation.
With regard to science and safety, the respondents
wanted scientific studies so that CAM would become
evidence based. They were concerned that unscientific
CAM methods and poorly qualified CAM practitioners
could lead to a deterioration of the disease. They
expressed an interest in testing different CAM methods
provided they were based on scientific evidence and a
few were positive towards participating in a clinical trial
to test them.
I think that it would be good if somebody carried out a
study, so that I could have the opportunity to test some
of it at a later stage. I can definitely envisage taking
part.
The respondents argued that it would feel safer to test
CAM if it was offered by the health services. They
respected the fact that HCPs have to work with
evidence-based methods and stated that they would be
positive towards working with CAM when research-
based evidence becomes available.
It’s easier to say Yes to something that you’re offered in
the hospital than in some room located in a basement.
The respondents were of the opinion that natural and
health-promoting remedies were not perceived as harm-
ful but that care should be exercised when taking them.
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to test them. I don’t think they can harm you.
Communication
The category Communication was based on the following
sub-categories: Patients’ perceptions of doctors’ and nurses’
attitudes to CAM, The relationship with the doctor, Re-
vealing CAM use and Wishing for a dialogue about CAM.
The respondents perceived that the doctors and nurses
lacked knowledge and were reluctant to talk about CAM
and therefore considered the care to be inadequate.
They reported having received no support from the
healthcare service in terms of CAM use and that it was
unusual for HCPs to discuss CAM. Some mentioned not
having been taken seriously as well as treated in a dis-
paraging manner when trying to discuss CAM. They
were also critical of the dietary advice provided, arguing
that HCPs should discuss diet more often with patients
suffering from IBD.
HCPs say: if you experience no adverse effect from it,
you can go ahead, but we don’t exactly support you
either.
HCPs don’t talk about CAM of their own accord.
When I became a vegetarian I was sneered at.
The respondents considered that doctors were more
sceptical than nurses when discussing CAM and that
they received a better response from the latter. However,
a few described HCPs’ attitude to CAM as dependent on
the individual as opposed to the group and that there
was no difference between nurses’ and doctors’ attitudes.
The respondents claimed that doctors remained more
faithful to their education and that HCPs did not see
CAM as a threat. Nevertheless, a few had the impression
that HCPs did not believe in CAM and that it was diffi-
cult to influence their negative attitude.
I think there’s a difference in nurses’ and doctors’
attitudes to CAM. Doctors have more to defend and
are more faithful to their education.
There were also some respondents who regarded the re-
lationship with the doctor as important. They trusted her/
him and appreciated being allowed to participate in their
care, as they wished to be actively involved in the discus-
sion about their disease and treatment. However, they
also stated that they complied with the doctor’s advice.
I believe in participation, it’s incredibly important to
me because I believe that everything has a better effect
if you’re involved.I’m very careful about ensuring that I know exactly
what is happening to me and my body and therefore
I’m actively involved in the discussions with my doctor.
On the question of whether to reveal their CAM use,
some did while others did not. Reasons for not revealing
their CAM use was feeling ashamed, the knowledge that
their doctor did not believe in CAM, respect for the doc-
tor and the fact that CAM is not a part of healthcare. They
did not mention it unless the HCPs asked them; it was up
to the patient to decide whether or not to talk about it.
You feel ashamed, perhaps you have done something
that is not quite OK or you don’t know what the
doctor will think about it, maybe out of respect for the
doctor.
I had a doctor who was a conventional doctor through
and through. I knew from the start that it wasn’t even
worth thinking about raising the subject.
The respondents reported wishing for a dialogue about
CAM and were open to discussing it as well as wanting
to obtain support and help with CAM treatment. They
found it easier to discuss with nurses than with doctors,
as they considered the former to have a more relaxed at-
titude to CAM, which was why they sometimes only told
nurses about their CAM use.
I want to change my diet completely, but I haven’t had
enough energy to tackle it. I would do it if I could get
support and help [from the HCPs].
But nurses are a bit more open to it [CAM]. It was
easier to have a dialogue with them about it.Self-care
The category Self-care comprised the sub-categories:
Making own choices, Living as normally as possible and
Searching for and obtaining CAM knowledge.
The respondents considered that making one’s own
choices, being able to influence and doing something
oneself were important, believing this to be the reason
some turned to CAM.
I think having an opportunity to influence one’s own
situation makes people feel good. Take dietary change
as an example, I think it makes a difference that you
can sort of control it yourself.
The respondents wished to live as normally as pos-
sible, did not want to change their lifestyle but to be able
to eat the same food as their family and friends. They
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could easily adapt to, as they found it difficult to keep to
a diet in everyday life and some did not have enough
strength to undertake major dietary changes.
I like to eat the same as my family and friends when
we are out together.
It’s difficult to stick to such a diet on working days. I
gradually went back to my previous diet and then it
became worse again.
The respondents searched for and obtained CAM
knowledge via the Internet if and when they needed it.
Some talked to and shared experiences with other
patients.
You try to talk to other patients to find out their
experiences.Discussion
The experiences of patients suffering from IBD demon-
strate that knowledge and communication about CAM
use in the context of healthcare promote patient partici-
pation in the area of CAM.
The main finding was that the respondents perceived
that HCPs were reluctant to discuss CAM, as well as
treating them in a disparaging manner and not taking
them seriously when they raised the subject. Interest-
ingly enough, this finding is in contrast to our earlier re-
search, which indicated that HCPs believed that they
emphasized the importance of the need to treat patients
with respect when informed about their CAM use [45].
Studies have shown that HCPs lack education about
CAM [39,40,45], which could be one reason patients’
interest in it was not taken seriously.
In Sweden, patients can report dissatisfaction with
healthcare to the Patients’ Advisory Committee (Patient-
nämnden). In the period 2006–2007, 13% of reports
concerned patients being encountered in a wrong or dis-
respectful manner, which constituted the fourth most
common complaint. How often such complaints were
related to CAM use was not reported [46]. The result of
the present study indicates a lack of communication be-
tween HCPs and patients with IBD. Some patients in-
formed the HCPs about their CAM use while others did
not. The reasons for not disclosing CAM use was
shame, anticipation of disapproval or non-inquiry on the
part of the doctor. This result is in line with previous re-
search on CAM use in patients with cancer [47-49]. IBD
professionals considered it crucial to create trust and a
good relationship with the patient and for this reason
did not ask about CAM, as they feared that suchquestions could have a negative impact on the relation-
ship [45]. The results of the present study indicate the
opposite, namely that patients suffering from IBD
wanted to be asked about CAM use, but that if HCPs
fail to do so, the patient her/himself will not mention it.
Patients with IBD do not communicate freely with
their physicians about CAM [50]. In this study the re-
spondents wanted a dialogue with HCPs about CAM.
Some of the respondents found it easier to discuss CAM
treatment with a nurse than with a doctor. The require-
ments of the Nurses-European Crohn’s and Colitis
Organization (N-ECCO) include, among other things,
the needs of patients’ with IBD, developing an empath-
etic and active listening role as well as providing essen-
tial IBD-related information and holistic support [51].
This clearly indicates that the role of IBD nurses is valu-
able in communication about and monitoring of CAM
use. The patients need information about their disease.
A full ten years after diagnosis, many patients with IBD
were of the opinion that they had not received sufficient
information about issues they now considered would
have been essential to have discussed at the time of
diagnosis [52].
Dietary changes are not clearly stated in NCCAM’s
definition of CAM, although in this study the respon-
dents expressed that dietary change was a part of CAM.
Some patients feel dietary manipulation may be benefi-
cial for them. These results are in line with Zallot et al.,
who demonstrated that patients suffering from IBD try
to implement dietary changes and avoid certain foods.
Fifty-eight percent of their respondents believed that
food played a role in disease relapse [53]. The respon-
dents stated that HCPs were not supportive when it
came to implementing dietary changes in daily life. One
reason could be the lack of evidence of therapeutic
benefit of dietary interventions in IBD, thus studies of
such interventions are urgently required [54,55]. How-
ever, research has revealed that a high protein diet, espe-
cially one rich in animal protein, may be associated with
an increased risk of IBD [56-59]. In the present study
the respondents considered self-care vital, wanted to live
as normally as possible and placed great value on
making their own decisions. A Canadian study showed
that patients with IBD and Irritable Bowel Syndrom
(IBS) used diet as a behavioural factor to control and
minimize their symptoms [60]. Zallot et al. found (2013)
that a large number of patients with IBD avoided certain
foods and reported that food had a major impact on
their social life [53].
The respondents in the present study wished for dia-
logue about CAM to enable their participation in the
treatment. Healthcare in Sweden is regulated by the
Health Care Act [6], which states that HCPs should pro-
vide the patient with information and involve her/him in
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participation. However, for the patient, participation
means “being involved in a life situation” rather than just
taking part in decisions about care and treatment [61].
This is something HCPs need to consider in order to
meet patient expectations by improving patient partici-
pation in the area of CAM and creating opportunities
for CAM discussions.
Methodological considerations
The qualitative study design allowed the respondents to
talk freely about their experiences of CAM. The analyses
reveal their experiences by means of their words and
statements. To strengthen the internal validity, criteria
for trustworthiness were applied; credibility, transferabil-
ity, dependability and conformability [44].
Credibility was strengthened by selecting respondents
of different ages, gender, disease duration and with a
diagnosis of UC or CD. The respondents were informed
that participation was voluntary and that they could
withdraw at any time. Furthermore, three of the authors
(AL, BF, LO) independently read the interviews, coded
them and discussed the analysis until consensus was
achieved. Transferability was ensured by the rich de-
scriptions of the phenomenon, even in the shortest
interview, which lasted for 15 minutes. The context was
described, which also supports transferability. Depend-
ability was enhanced by a description of the research
process and design. The last area of trustworthiness
mentioned by Lincoln and Guba [44] is conformability;
i.e. the researcher should remain objective. The first
author (AL) who conducted the interviews has been
employed as an IBD nurse and worked with such pa-
tients for 15 years but was not involved in the care of
the respondents. To prevent bias in the analysis due to
pre-understanding, all authors independently read and
analysed the text, after which disagreements were dis-
cussed and consensus achieved. However, in qualitative
studies, the credibility of the researcher is of major im-
portance, thus the present author’s pre-understanding
can be considered a strength as it ensured knowledge
and comprehension of the context [43].
Conclusion
The experiences of patients with IBD demonstrated that
HCPs were reluctant to discuss CAM, and some treated
them in a disparaging manner and did not take them
seriously when they raised the subject. They wanted to
be asked about CAM in order to engage in a dialogue.
HCPs must be aware of this, so that they can meet and
understand patient needs. The finding that patients con-
sidered it easier to discuss CAM with nurses than physi-
cians highlights the important role of IBD nurses in
providing information about and monitoring CAM use.HCPs also need to understand that dietary changes are
an important aspect of CAM treatment for many pa-
tients who suffer from IBD. Further research in these
areas is needed.
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